In an era of increasingly bespoke healthcare, Elizabeth Philp has emerged as a formidable figure of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make bespoke medications more accessible, questioning the traditional one-size-